Advertisement
Advertisement

China’s Zhengzhou, Shenyang to tighten COVID rules

By:
Reuters
Updated: Nov 23, 2022, 15:21 UTC

BEIJING (Reuters) - Eight districts in the central Chinese city of Zhengzhou will conduct mass COVID-19 testing for five consecutive days from Nov. 25, state television CCTV reported on Wednesday.

Residents line up for nucleic acid testing following COVID-19 outbreak in Zhengzhou

BEIJING (Reuters) – Eight districts in the central Chinese city of Zhengzhou will conduct mass COVID-19 testing for five consecutive days from Nov. 25, state television CCTV reported on Wednesday.

Residents in “high-risk” compounds are required to stay at home, while those living in other areas should not go out unless necessary, CCTV reported.

People are not allowed to enter venues such as restaurants, shopping malls and indoor gyms within five days of arriving in Zhengzhou city, and need to complete three PCR tests within these days, local media reported, citing a media briefing.

They can take public transport after completing the first COVID test after arrival, according to local media.

The central city reported 996 COVID positive cases in the primary screening as of 8 p.m.(1200 GMT) on Wednesday, CCTV said.

Separately, the northeastern Chinese city of Shenyang is also tightening rules to combat the latest COVID-19 flare-ups, CCTV reported.

The city will conduct regional PCR tests in nine districts from Nov. 24 to Nov. 28, strictly curb non-essential movement of people, and suspend dine-in services in these areas, it said.

(Reporting by Ella Cao and Twinnie Siu; Editing by Gareth Jones, William Maclean)

About the Author

Reuterscontributor

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products:

Did you find this article useful?

Advertisement